Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1998-8-19
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0145-2126
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
383-4
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9669844-Cell Cycle,
pubmed-meshheading:9669844-G2 Phase,
pubmed-meshheading:9669844-Genes, Wilms Tumor,
pubmed-meshheading:9669844-Humans,
pubmed-meshheading:9669844-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:9669844-Mitosis,
pubmed-meshheading:9669844-Oligonucleotides, Antisense,
pubmed-meshheading:9669844-Tumor Cells, Cultured
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Suppression of Wilms' tumor gene (WT1) expression induces G2/M arrest in leukemic cells.
|
| pubmed:publicationType |
Letter
|